Philip A. Pizzo, Director at Global Blood Therapeutics, Inc. (GBT), sold 1,260 shares at $27.25 ($34K) on 2022-06-21, disclosed to the SEC on 2022-06-22.
Scheduled sale ($34k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |